Adma Biologics Cash Flow Statement (2011-2025) | ADMA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-18.34M	-18.82M	-17.73M	-25.15M	-18.17M	-13.75M	-14.89M	-18.64M	-6.79M	-6.37M	2.56M	10.59M	17.81M	32.06M	35.91M	49.87M	26.90M	34.22M	36.43M	-133.28M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	0.78M	0.81M	0.69M	1.21M	1.64M	1.19M	1.31M	1.07M	1.11M	1.64M	1.70M	1.75M	2.14M	2.86M	3.18M	5.43M	4.62M	4.96M	5.05M	5.39M
Deferred Taxes (Quarter)																84.28M	3.42M	1.62M	4.80M	-20.87M
Cash from Operations (Quarter)	-33.23M	-32.26M	-13.41M	-33.47M	-26.01M	-12.83M	-13.28M	-7.38M	-14.72M	-6.06M	11.98M	17.60M	-2.22M	45.65M	25.03M	50.22M	-19.68M	21.14M	13.29M	35.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.44M	0.46M	0.49M	0.50M	0.58M	0.34M	0.98M	0.49M	0.49M	0.69M	0.72M	0.70M	0.25M	0.23M	0.25M	0.22M	0.19M	0.16M	0.17M	0.20M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	1.23M	1.33M	1.42M	1.52M	1.59M	1.72M	1.86M	1.94M	2.03M	2.10M	2.09M	2.11M	2.11M	2.05M	1.94M	1.94M	1.97M	2.06M	2.02M	2.05M
Change in Working Capital
Change in Receivables (Quarter)	2.12M	8.18M	-3.15M	8.18M	-2.95M	-6.75M	2.02M	-5.40M	11.01M	10.21M	-5.41M	-3.90M	22.20M	-19.51M	20.03M	-0.14M	49.41M	10.31M	27.95M	20.76M
Change in Inventory (Quarter)	12.61M	5.55M	14.42M	10.60M	14.42M	6.93M	16.84M	0.37M	0.70M	-2.21M	1.34M	9.79M	4.83M	2.08M	-8.01M	-1.57M	1.95M	19.28M	5.20M	9.80M
Change in Account Payables (Quarter)	1.08M	-5.99M	11.12M	-4.85M	1.69M	-2.73M	13.81M	-11.97M	-0.27M	-0.87M	-0.01M	4.99M	0.45M	-1.86M	1.62M	3.94M	0.14M	9.27M	-4.88M	-2.20M
Change in Accured Expenses (Quarter)	-0.03M	-0.03M	5.59M	-5.31M	-1.78M	0.31M	1.10M	-0.14M	-1.35M	6.09M	0.14M	-5.66M	0.68M	-5.87M	5.64M	0.27M	-0.65M	0.05M	-0.23M	-0.40M
Other Working Capital Changes (Quarter)	2.76M	-0.10M	0.16M	-1.52M	1.18M	-0.12M	-0.03M	-0.28M	-0.72M	0.84M	-0.11M	0.23M	-1.59M	1.78M	4.02M	-1.52M	2.60M	-0.50M	-1.12M	0.55M
Investing Activities
Capital Expenditures (Quarter)	2.57M	4.48M	2.79M	3.68M	2.84M	3.94M	3.38M	3.75M	1.95M	0.87M	0.76M	1.20M	2.35M	2.07M	1.06M	2.76M	4.70M	2.42M	14.37M	1.08M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-2.57M	-4.48M	-2.79M	-3.68M	-2.84M	-3.94M	-3.38M	-3.75M	-1.95M	-0.87M	-0.76M	-1.41M	-2.36M	-2.37M	-1.10M	-2.75M	-4.72M	-2.53M	-14.37M	-0.28M
Financing Activities
Other financing activities (Quarter)					2.38M		0.40M	72.00		0.47M	0.62M	0.01M	1.03M	0.33M	5.69M	-7.05M	0.10M	2.06M	0.39M	0.43M
Cash from Financing Activities (Quarter)	41.84M	17.18M	8.20M	53.82M	47.27M	-0.32M	-0.84M	62.74M	-0.65M	0.24M	0.42M	-38.99M	-1.45M	-0.36M	-25.47M	-31.03M	-7.13M	0.05M	-27.82M	-9.12M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)	41.91M	17.19M	8.21M	53.83M				64.64M
Additional items
Change in Cash (Quarter)	6.04M	-19.56M	-8.00M	16.68M	18.42M	-17.09M	-17.51M	51.62M	-17.32M	-6.69M	11.64M	-22.80M	-6.03M	42.92M	-1.54M	16.44M	-31.52M	18.66M	-28.90M	26.25M
Free Cash Flow (Quarter)	-35.80M	-36.74M	-16.20M	-37.14M	-28.86M	-16.77M	-16.67M	-11.13M	-16.67M	-6.93M	11.23M	16.40M	-4.57M	43.58M	23.97M	47.46M	-24.38M	18.72M	-1.07M	34.55M
Net Cash Flow (Quarter)	6.04M	-19.56M	-8.00M	16.68M	18.42M	-17.09M	-17.51M	51.62M	-17.32M	-6.69M	11.64M	-22.80M	-6.03M	42.92M	-1.54M	16.44M	-31.52M	18.66M	-28.90M	26.25M

Research Tools

Developers

Adma Biologics Cash Flow Statement (2011-2025) | ADMA

Research Tools

Developers

Adma Biologics Cash Flow Statement (2011-2025) | ADMA

Create an account

Sign In

Reset Password